Hims & Hers Super Bowl Spot Draws Drug-Industry Backlash Telehealth provider Hims & Hers Health is defending its Super Bowl ad, which is styled as a political manifesto against…
Drug industry groups target Hims & Hers Super Bowl ad touting weight loss drug Drug industry calls out telehealth company Hims & Hers Super Bowl ad touting its knock-off weight loss medications.…
Hims & Hers Super Bowl commercial: Ad draws ire from drug industry Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for weight loss medications.…
Two U.S. senators slammed an S.F. telehealth company’s Super Bowl ad. Here’s why Sens. Dick Durbin, D-Ill., and Roger Marshall, R-Kan., said Hims & Hers didn’t...…
FDA should throw the yellow flag on Hims & Hers ad GUEST COMMENTARY: Why does Hims seem to be able to ignore the statutes and rules that are enforced by the…
Hims & Hers Super Bowl commercial draws lawmaker scrutiny A TV commercial that the telehealth company Hims & Hers Health (NYSE:HIMS) is planning to run during the upcoming Super…
Hims & Hers Super Bowl ad draws lawmaker scrutiny (HIMS:NYSE) Hims & Hers Health (HIMS) stock courts controversy as its Super Bowl commercial for weight loss products draws lawmaker scrutiny.…
Hims & Hers Health (NYSE:HIMS) Hits New 1-Year High Hims & Hers Health (NYSE:HIMS) Hits New 12-Month High - Whats Next?…
Drug industry groups target Hims & Hers Super Bowl ad touting weight loss drug Drug industry calls out telehealth company Hims & Hers Super Bowl ad touting its knock-off weight loss medications.…
Hims & Hers’ Big Game Ad Comes Under Fire A :60 for weight loss drug Hims & Hers, set to air during Sundays Super Bowl telecast, is drawing intense…
Hims & Hers responds to controversy over Super Bowl weight loss drug commercial: Were calling for change Healthcare groups and lawmakers are calling the ad "misleading."…
Hims & Hers responds to controversy over Super Bowl weight loss drug commercial: Were calling for change On Sunday, Hims & Hers Health will have a commercial air during Super Bowl LIX. It’s already courting controversy, with…
Hims and Hers Superbowl Ad Draws Controversy Over Safety The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad…
Hims & Hers faces scrutiny from senators on Super Bowl ad that risks misleading patients Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super…
Alliance for Pharmacy Compounding responds to Hims & Hers Super Bowl Ad The Hims & Hers planned Super Bowl ad buy – and the content of that ad – is noteworthy, but…
Hims & Hers faces backlash over misleading Super Bowl ad—but it didnt stop stock from jumping over 11% The telehealth company defended its ad with a defiant statement: Weve called out the system and now the system is…
Senators ask FDA to dig into misleading Super Bowl ad from Hims Sens. Dick Durbin (D-IL) and Roger Marshall (R-KS) are calling on the FDA to take action against a Super Bowl…
Hims & Hers faces scrutiny from lawmakers over misleading Super Bowl ad Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super…
Hims Promises Affordable Weight Loss—But Is It Just a $79 Monthly Pipe Dream? Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care products. Hims is part of…
Why Hims & Hers Health (HIMS), Tempus AI (TEM) and Teladoc (TDOC) Are Up Big Today Stock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating…
Hims & Hers stands firms in face of PhRMA slur Trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has accused one of the country’s largest compounders, Hims &…
Hims & Hers jumps ahead of controversial Super Bowl ad airing Shares of Hims Hers (HIMS) have jumped on Friday as the company is preparing to air its first Super…
Hims & Hers stock up ahead of Super Bowl ad (HIMS:NYSE) Hims & Hers Health (HIMS) stock hits an all-time high as the companys controversial Super Bowl ad is set to…
Hims and Hers Super Bowl Ad Sparks Controversy Over Weight Loss Drugs The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about…
Pharmalittle: Were reading about a Hims Super Bowl ad, USAID freeze hurting clinical trial patients, and more Lawmakers want the FDA to review whether a Super Bowl ad from Hims & Hers runs afoul of pharmaceutical advertising…
Hims & Hers Stock (HIMS) Falters on Backlash Over Super Bowl Ad Telehealth company Hims Hers Health ($HIMS) recently stirred up controversy with its ad promoting its compounded weight-loss drugs aired…
Zepbound sales double, tariffs could hit Ozempic, and Pfizer on RFK Jr.: Pharma news roundup Plus, a pharma group targets Hims & Hers Super Bowl ad and Novo Nordisk projects slowing growth in 2025…
Hims & Hers Health (NYSE:HIMS) Stock Price Up 4.5% Hims & Hers Health (NYSE:HIMS) Stock Price Up 4.5% - Whats Next?…